Magnetic Mitohormesis: Effect of Magnetic Signals on Metabolic Adaptions in Type 2 Diabetes (MENSA-T2D) (MENSA-T2D)

Inclusion Criteria: Age 40-75 years T2DM of at least 6 months duration HbA1c between 7.0% - 10.0% (most recent 3-months prior to enrolment) Body Mass Index (BMI) between 23.0 and 32.5 kg/m2 Able to ambulate independently Willing and able to give written informed consent Exclusion Criteria: Presence of any conditions contraindicated for PEMF exposures (e.g. active electronic implants, pregnancy, pacemakers, implantable defibrillators) Medical advice against physical activity Chest pain when performing physical activity Chest pain at rest BP > 180/90 mmHg Women who are lactating, pregnant or considering pregnancy Cancer not in remission or receiving active cancer treatment Current participation in another clinical trial Systemic steroid usage (eg. prednisolone, hydrocortisone, cortisone, dexamethasone) Uncontrolled thyroid disease Significant alcohol intake (> 1 unit per day for women and > 2 units per day for men) Any factors likely to limit adherence to study protocol (e.g. dementia; alcohol or substance abuse; history of unreliability in medication taking or appointment keeping; significant concerns about participation in the study from spouse, significant other or family members) Anticipated surgery or changes in diabetes medications during the study duration History of severe hypoglycaemia in the recent 3 months Have used the MM device in the past 3 months Had a recent surgical procedure in the last 6 months, where muscle activation can interfere with the healing response